If US Court's Decision Against Gene Patenting Sticks, Will EU Researchers Take Up Similar Cause?

European geneticists have had some success in blunting the impact of BRCA patents on their research, but the structure of the European patent system has barred them from broadly challenging gene patents in the way the ACLU and PUBPAT have in the US.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.